Sort
130,381 grants matching “hiv”
Advancing Vaccine Adjuvant Research for Tuberculosis (TB)
$2,000,000Warwick Britton · University Of Sydney · N01 · FY2025 · AI
LEVERAGEING MMC FOR HIV PREVENTION IN KWAZULU-NATAL
$2,000,000Malebo Maponyane · Catholic Medical Mission Board, Inc. · U2G · FY2011 · GH
Nanovaccine for Eliciting bnAbs Against HIV-1
$2,000,000Santanu Raychaudhuri · Neovaxsyn, Inc. · N44 · FY2024 · AI
PROVISION OF VOLUNTARY MEDICAL MALE CIRCUMCISION (VMMC) FOR HIV PREVNTION IN EIGH
$2,000,000Emma Llewellyn · Nyanza Reproductive Health Society · U2G · FY2009 · PS
Adjuvant Comparison and Characterization (HIV)
$1,999,999Bali Pulendran · Stanford University · N01 · FY2024 · AI
RFA-PS-23-001 - Project PrOVIDE: PrEP Optimization Via Implementation, Dissemination, and Evaluation
$1,999,998Amy Kristen Johnson · Lurie Children'S Hospital Of Chicago · U01 · FY2023 · PS
CNT-VECTORED DELIVERY OF MRNA FOR HIV-VACCINES
$1,999,997Yang Xu · Luna Innovations, Inc. · N44 · FY2019 · AI
A Multifunctional Point of- Care Platform to Differentiate HIV Infection from Vaccine Induced Seropositivity
$1,999,995Ranier Ng · Baebies, Inc. · N43 · FY2025 · AI
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS
$1,999,984Barbara Driver · Westat, Inc. · N01 · FY2025 · HD
Hit-to-Lead Progression Studies on Interventional Agents: Identification of Lead Compounds to Inhibit HIV-1
$1,999,962Roger Ptak · Southern Research Institute · N01 · FY2018 · AI
Alcohol, HIV Infection and Host Defense
$1,999,949Steve Nelson · Lsu Health Sciences Center · P60 · FY2010 · AA
Flow cytometric analysis of benign and malignant tumors
$1,999,901Hao-Wei Wang · Division Of Clinical Sciences - Nci · ZIC · FY2023 · CA
HIV NEUROBEHAVIORAL RESEARCH CENTER
$1,999,891University Of California San Diego · P30 · FY2001 · MH
Design and Engineering of VesiVax HIV Immunogen Formulations
$1,999,866Samon Ho · Molecular Express, Inc. · N44 · FY2024 · AI
Protection against Mucosal SIV Challenge by Adeno-Associated Virus Delivery of Env-Specific Antibodies
$1,999,460Maria Ferrari · Bioqual, Inc. · N01 · FY2023 · AI
The Asia-Pacific HIV Research Collaboration
$1,999,016David A Cooper · Foundation For Aids Research · U01 · FY2015 · AI
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$1,999,002Roger L Shapiro · Harvard School Of Public Health · U01 · FY2021 · AI
RFA-PS-23-001 - Project PrOVIDE: PrEP Optimization Via Implementation, Dissemination, and Evaluation
$1,998,696Amy Kristen Johnson · Lurie Children'S Hospital Of Chicago · U01 · FY2025 · PS
MyPEEPS Mobile LITE: Limited Interaction Efficacy Trial of MyPEEPS Mobile to Reduce HIV Incidence and Better Understand the Epidemiology of HIV among YMSM
$1,998,069Rebecca Schnall · Columbia University Health Sciences · UG3 · FY2023 · AI
Immunogen Design for Specific BCR Activation
$1,997,824Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · U19 · FY2020 · AI
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies
$1,997,665Reuben S Harris · University Of Minnesota · P01 · FY2013 · GM
National HIV Surveillance System
$1,997,625Bridget J. Anderson · Nysdoh/Health Research, Inc. · U62 · FY2013 · PS
IGF::OT::IGF "HUMANIZED MOUSE MODELS FOR HIV THERAPEUTICS DEVELOPMENT"
$1,997,581Cheryl Stoddart · University Of California, San Francisco · N01 · FY2015 · AI
Multilevel strategies to understand and modify the role of structural and environmental factors in HIV outcomes (LITE-2)
$1,997,143Tamara Taggart · Rutgers Biomedical And Health Sciences · UH3 · FY2025 · AI
Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention
$1,997,089Robert Rodick · Vxbiosciences, Inc. · R01 · FY2023 · AI